Healthequity (NASDAQ:HQY) Lifted to “Hold” at BidaskClub

BidaskClub upgraded shares of Healthequity (NASDAQ:HQY) from a sell rating to a hold rating in a research report sent to investors on Wednesday morning, BidAskClub reports.

A number of other equities research analysts also recently weighed in on the stock. Bank of America set a $79.00 price target on shares of Healthequity and gave the stock a buy rating in a research note on Wednesday, September 4th. JPMorgan Chase & Co. set a $80.00 price target on shares of Healthequity and gave the stock an overweight rating in a research note on Wednesday, June 5th. KeyCorp dropped their price target on shares of Healthequity from $90.00 to $70.00 and set an overweight rating for the company in a research note on Tuesday. ValuEngine downgraded shares of Healthequity from a buy rating to a hold rating in a research note on Tuesday, August 6th. Finally, Oppenheimer dropped their price target on shares of Healthequity from $98.00 to $76.00 and set an outperform rating for the company in a research note on Wednesday, September 4th. Three equities research analysts have rated the stock with a hold rating, ten have given a buy rating and one has given a strong buy rating to the company’s stock. Healthequity currently has an average rating of Buy and a consensus target price of $78.92.

Shares of NASDAQ HQY opened at $60.89 on Wednesday. Healthequity has a 1-year low of $50.29 and a 1-year high of $101.58. The company has a market cap of $4.33 billion, a PE ratio of 53.30, a P/E/G ratio of 3.55 and a beta of 1.55. The company has a current ratio of 22.98, a quick ratio of 22.98 and a debt-to-equity ratio of 0.04. The company has a 50-day moving average of $63.87 and a two-hundred day moving average of $69.82.

Healthequity (NASDAQ:HQY) last posted its quarterly earnings results on Tuesday, September 3rd. The company reported $0.36 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.26 by $0.10. The business had revenue of $86.60 million during the quarter, compared to the consensus estimate of $85.33 million. Healthequity had a net margin of 28.13% and a return on equity of 11.77%. Healthequity’s revenue for the quarter was up 21.8% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.36 earnings per share. As a group, equities research analysts forecast that Healthequity will post 0.87 earnings per share for the current year.

In other news, CEO Jon Kessler acquired 10,000 shares of the firm’s stock in a transaction that occurred on Friday, July 12th. The stock was purchased at an average price of $61.00 per share, for a total transaction of $610,000.00. Following the completion of the acquisition, the chief executive officer now owns 442,410 shares in the company, valued at $26,987,010. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Darcy G. Mott sold 4,000 shares of the business’s stock in a transaction that occurred on Tuesday, August 20th. The shares were sold at an average price of $60.82, for a total transaction of $243,280.00. Following the transaction, the chief financial officer now owns 50,100 shares of the company’s stock, valued at approximately $3,047,082. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 33,899 shares of company stock valued at $2,464,691. Corporate insiders own 3.70% of the company’s stock.

A number of hedge funds and other institutional investors have recently modified their holdings of HQY. Dimensional Fund Advisors LP grew its holdings in Healthequity by 1.8% during the fourth quarter. Dimensional Fund Advisors LP now owns 505,825 shares of the company’s stock valued at $30,171,000 after purchasing an additional 8,813 shares during the period. Geode Capital Management LLC boosted its holdings in shares of Healthequity by 10.6% in the fourth quarter. Geode Capital Management LLC now owns 627,359 shares of the company’s stock valued at $37,421,000 after buying an additional 60,027 shares during the period. California Public Employees Retirement System boosted its holdings in shares of Healthequity by 0.5% in the first quarter. California Public Employees Retirement System now owns 96,985 shares of the company’s stock valued at $7,175,000 after buying an additional 487 shares during the period. Raymond James Financial Services Advisors Inc. boosted its holdings in shares of Healthequity by 8.2% in the first quarter. Raymond James Financial Services Advisors Inc. now owns 73,466 shares of the company’s stock valued at $5,435,000 after buying an additional 5,592 shares during the period. Finally, Raymond James & Associates boosted its holdings in shares of Healthequity by 6.8% in the first quarter. Raymond James & Associates now owns 58,883 shares of the company’s stock valued at $4,356,000 after buying an additional 3,737 shares during the period. Hedge funds and other institutional investors own 94.19% of the company’s stock.

About Healthequity

HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Featured Story: How to calculate compound interest

Analyst Recommendations for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.